Literature DB >> 27001762

The Impact of Prior Flavivirus Infections on the Development of Type 2 Diabetes Among the Indigenous Australians.

Alanna Sorenson1, Leigh Owens2, Marie Caltabiano3, Yvonne Cadet-James4, Roy Hall5, Brenda Govan2, Paula Clancy2.   

Abstract

It is estimated that 5% of Australians over the age of 18 have diabetes, with the number of new cases increasing every year. Type 2 diabetes (T2D) also represents a significant disease burden in the Australian indigenous population, where prevalence is three times greater than that of non-indigenous Australians. Prevalence of T2D has been found to be higher in rural and remote indigenous Australian populations compared with urban indigenous Australian populations. Several studies have also found that body mass index and waist circumference are not appropriate for the prediction of T2D risk in indigenous Australians. Regional and remote areas of Australia are endemic for a variety of mosquito-borne flaviviruses. Studies that have investigated seroprevalence of flaviviruses in remote aboriginal communities have found high proportions of seroconversion. The family Flaviviridae comprises several genera of viruses with non-segmented single-stranded positive sense RNA genomes, and includes the flaviviruses and hepaciviruses. Hepatitis C virus (HCV) has been shown to be associated with insulin resistance and subsequent development of T2D. Flaviviruses and HCV possess conserved proteins and subgenomic RNA structures that may play similar roles in the development of insulin resistance. Although dietary and lifestyle factors are associated with increased risk of developing T2D, the impact of infectious diseases such as arboviruses has not been assessed. Flaviviruses circulating in indigenous Australian communities may play a significant role in inducing glucose intolerance and exacerbating T2D. © The American Society of Tropical Medicine and Hygiene.

Entities:  

Mesh:

Year:  2016        PMID: 27001762      PMCID: PMC4973169          DOI: 10.4269/ajtmh.15-0727

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  44 in total

1.  Epizootic activity of Murray Valley encephalitis and Kunjin viruses in an aboriginal community in the southeast Kimberley region of Western Australia: results of mosquito fauna and virus isolation studies.

Authors:  Annette K Broom; Michael D A Lindsay; Anthony E Wright; David W Smith; John S Mackenzie
Journal:  Am J Trop Med Hyg       Date:  2003-09       Impact factor: 2.345

2.  A highly structured, nuclease-resistant, noncoding RNA produced by flaviviruses is required for pathogenicity.

Authors:  Gorben P Pijlman; Anneke Funk; Natasha Kondratieva; Jason Leung; Shessy Torres; Lieke van der Aa; Wen Jun Liu; Ann C Palmenberg; Pei-Yong Shi; Roy A Hall; Alexander A Khromykh
Journal:  Cell Host Microbe       Date:  2008-12-11       Impact factor: 21.023

Review 3.  Targeting inflammation in the treatment of type 2 diabetes: time to start.

Authors:  Marc Y Donath
Journal:  Nat Rev Drug Discov       Date:  2014-05-23       Impact factor: 84.694

4.  Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States.

Authors:  S H Mehta; F L Brancati; M S Sulkowski; S A Strathdee; M Szklo; D L Thomas
Journal:  Ann Intern Med       Date:  2000-10-17       Impact factor: 25.391

5.  Molecular phylogeny of edge hill virus supports its position in the yellow Fever virus group and identifies a new genetic variant.

Authors:  Joanne Macdonald; Michael Poidinger; John S Mackenzie; Richard C Russell; Stephen Doggett; Annette K Broom; Debra Phillips; Joseph Potamski; Geoff Gard; Peter Whelan; Richard Weir; Paul R Young; Debra Gendle; Sheryl Maher; Ross T Barnard; Roy A Hall
Journal:  Evol Bioinform Online       Date:  2010-06-15       Impact factor: 1.625

6.  HCV RNA in peripheral blood cell subsets in HCV-HIV coinfected patients at the end of PegIFN/RBV treatment is associated with virologic relapse.

Authors:  B de Felipe; M Leal; N Soriano-Sarabia; A Gutiérrez; L López-Cortés; S Molina-Pinelo; A Vallejo
Journal:  J Viral Hepat       Date:  2008-08-28       Impact factor: 3.728

7.  Hypertriglyceridemic waist and newly-diagnosed diabetes among remote-dwelling Indigenous Australians.

Authors:  M Daniel; C Paquet; S J Kelly; G Zang; K G Rowley; R McDermott; K O'Dea
Journal:  Ann Hum Biol       Date:  2013-07-19       Impact factor: 1.533

8.  MicroRNA 144 impairs insulin signaling by inhibiting the expression of insulin receptor substrate 1 in type 2 diabetes mellitus.

Authors:  Dwi Setyowati Karolina; Arunmozhiarasi Armugam; Subramaniam Tavintharan; Michael T K Wong; Su Chi Lim; Chee Fang Sum; Kandiah Jeyaseelan
Journal:  PLoS One       Date:  2011-08-01       Impact factor: 3.240

Review 9.  Noncoding subgenomic flavivirus RNA: multiple functions in West Nile virus pathogenesis and modulation of host responses.

Authors:  Justin A Roby; Gorben P Pijlman; Jeffrey Wilusz; Alexander A Khromykh
Journal:  Viruses       Date:  2014-01-27       Impact factor: 5.048

Review 10.  The changing epidemiology of Kunjin virus in Australia.

Authors:  Natalie A Prow
Journal:  Int J Environ Res Public Health       Date:  2013-11-25       Impact factor: 3.390

View more
  1 in total

1.  Blood glucose promotes dengue virus infection in the mosquito Aedes aegypti.

Authors:  Shih-Che Weng; Po-Nien Tsao; Shin-Hong Shiao
Journal:  Parasit Vectors       Date:  2021-07-26       Impact factor: 3.876

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.